Literature DB >> 2494115

Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.

S D Desai1, T J Birdi, N H Antia.   

Abstract

The killing of Mycobacterium leprae by resting and gamma interferon (IFN-gamma)-activated macrophages in normal subjects and leprosy patients was assessed. Resting macrophages from normal individuals demonstrated the ability to kill M. leprae. For macrophages from tuberculoid patients, killing of M. leprae was only achieved in the presence of IFN-gamma, suggesting that initial T-cell activation occurs prior to the killing of M. leprae. In contrast, though activation with IFN-gamma rendered the lepromatous macrophages microbicidal, it failed to induce lymphocyte proliferation, suggesting a defect at either the antigen-presenting cell or the lymphocyte level or both. The concept that T-cell anergy is primarily due to lack of lymphokine generation was ruled out by our results, since responsiveness was restored in only a small proportion of lepromatous patients after exogenous lymphokine addition. In conclusion, this study demonstrated that killing and antigen presentation are two independent events. It appears that the ability of the macrophages per se to kill M. leprae may be of greater importance than lymphocyte-mediated activation for protection against M. leprae infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494115      PMCID: PMC313267          DOI: 10.1128/iai.57.4.1311-1317.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Mediator-induced macrophage activation, as shown by enhanced cytotoxicity for tumor, requires macrophage surface fucose and sialic acid.

Authors:  W H Churchill; C Wong
Journal:  Cell Immunol       Date:  1980-10       Impact factor: 4.868

2.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

3.  The role of macrophages in leprosy as studied by protein synthesis of macrophages from resistant and susceptible hosts--a mouse and human study.

Authors:  T J Birdi; P R Salgame; N H Antia
Journal:  Lepr India       Date:  1979-01

4.  Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

Authors:  M Sathish; L K Bhutani; A K Sharma; I Nath
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

5.  Mechanism of immunosuppression in leprosy: presence of suppressor factor(s) from macrophages of lepromatous patients.

Authors:  P R Salgame; P R Mahadevan; N H Antia
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Alterations in the membrane of macrophages from leprosy patients.

Authors:  T J Birdi; N F Mistry; P R Mahadevan; N H Antia
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

7.  Incorporation of 3H-thymidine in Mycobacterium leprae within differentiated human macrophages.

Authors:  H K Prasad; I Nath
Journal:  J Med Microbiol       Date:  1981-08       Impact factor: 2.472

8.  MYCOBACTERIUM LEPRAE IN MICE: MINIMAL INFECTIOUS DOSE, RELATIONSHIP BETWEEN STAINING QUALITY AND INFECTIVITY, AND EFFECT OF CORTISONE.

Authors:  C C SHEPARD; D H MCRAE
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

9.  Macrophage-lymphocyte interaction. II. Antigen-mediated physical interactions between immune guinea pig lymph node lymphocytes and syngeneic macrophages.

Authors:  P E Lipsky; A S Rosenthal
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

10.  Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.

Authors:  N Nogueira; G Kaplan; E Levy; E N Sarno; P Kushner; A Granelli-Piperno; L Vieira; V Colomer Gould; W Levis; R Steinman
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  8 in total

1.  Lipids from Mycobacterium leprae cell wall are endowed with an anti-inflammatory property and inhibit macrophage function in vivo.

Authors:  A C Moura; M Mariano
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

2.  Regulation of expression of major histocompatibility antigens by bovine macrophages infected with Mycobacterium avium subsp. paratuberculosis or Mycobacterium avium subsp. avium.

Authors:  D J Weiss; O A Evanson; D J McClenahan; M S Abrahamsen; B K Walcheck
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Lipids from Mycobacterium leprae cell wall suppress T-cell activation in vivo and in vitro.

Authors:  A C Moura; M Mariano
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

4.  A complex component modulating immune-deficient cells in leprosy patients leading to loss of viability of Mycobacterium leprae--a possible vaccine.

Authors:  J Marolia; P Robinson; P R Mahadevan
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

5.  Effects of treatment on the histopathology of leprosy.

Authors:  I A Cree; G Coghill; A M Subedi; N C Abbot; S R Butlin; P D Samson; J S Beck
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

6.  Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric oxide.

Authors:  M Tohyama; K Kawakami; M Futenma; A Saito
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

7.  Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation.

Authors:  Willis Huang; Regis J O'Keefe; Edward M Schwarz
Journal:  Arthritis Res Ther       Date:  2002-11-12       Impact factor: 5.156

8.  Blood coagulation abnormalities in multibacillary leprosy patients.

Authors:  Débora Santos da Silva; Lisandra Antonia Castro Teixeira; Daniela Gois Beghini; André Teixeira da Silva Ferreira; Márcia de Berredo Moreira Pinho; Patricia Sammarco Rosa; Marli Rambaldi Ribeiro; Monica Di Calafiori Freire; Mariana Andrea Hacker; José Augusto da Costa Nery; Maria Cristina Vidal Pessolani; Ana Maria Freire Tovar; Euzenir Nunes Sarno; Jonas Perales; Fernando Augusto Bozza; Danuza Esquenazi; Robson Queiroz Monteiro; Flavio Alves Lara
Journal:  PLoS Negl Trop Dis       Date:  2018-03-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.